Addressing Disparities and Underutilization of Adolescent Metabolic and Bariatric Surgery

医学 社会心理的 肥胖 体质指数 人口 儿童肥胖 儿科 医疗保健 家庭医学 梅德林 误传 超重 老年学 精神科 环境卫生 内科学 政治学 法学 经济 经济增长
作者
Marc P. Michalsky,Janey Pratt
出处
期刊:Pediatrics [American Academy of Pediatrics]
卷期号:153 (3)
标识
DOI:10.1542/peds.2023-064375
摘要

In response to the unremitting rise of childhood obesity in the United States,1,2 a growing body of literature supports the utilization of metabolic and bariatric surgery (MBS) for the treatment of severe obesity (body mass index [BMI] ≥120% of the 95th percentile or BMI ≥35 kg/m2) in the pediatric population.3–5 In addition to offering important insight regarding the physiologic and psychosocial phenotypes observed among individuals presenting for MBS, numerous studies to date have shown improvement and/or complete resolution of most comorbid conditions with significant improvements in quality of life. Despite favorable results and a recent rise in procedural prevalence, ongoing controversy, including professional bias related to the treatment of childhood obesity and misinformation among the general public, access to care remains limited compared with the corresponding adult population.6–10 In a series of recently published policy statements and clinical practice guidelines, the American Academy of Pediatrics (AAP) and the American Society of Metabolic and Bariatric Surgery have recommended approaches to address disparities in the use of MBS in the pediatric population and have unambiguously stated that pediatric health care providers should refer eligible patients to comprehensive multidisciplinary pediatric MBS centers.2–4In this issue of Pediatrics, Shapiro et al describe the proportion of adolescents receiving care in a large multicenter health care system in Southern California that met clinical criteria to receive MBS.11 Among the 603 041 adolescents included in the analysis, 9.3% (n = 56 082) were classified as having class 2 obesity or higher (5.4% class 2 and 3.9% class 3), thus satisfying anthropomorphic qualifications for bariatric surgical eligibility. Interestingly, the initial exclusion of 10 individuals from the analysis cohort because of a history of having had a bariatric procedure, representing a procedural prevalence of only 0.002%, stands out as a striking reminder of the relative infrequency of MBS in the pediatric population. Additionally, the low frequency of MBS highlights the disparity of access to care compared with the procedural prevalence (1%) often cited in the adult population.12,13Although the current study offers important insights into patient eligibility and associated availability of MBS, it also highlights important limitations associated with retrospective analysis of large administrative data sets that should prompt the need for additional prospective and uniform multi-institutional studies. For example, although the reported prevalence of obesity with the study cohort (22.2%) appears to align with previous reports, including 10% being considered class 2 obesity or higher, the associated prevalence of related comorbid diseases across the entirety of the cohort may be a gross underestimation in that the authors found only 3.2% had gastroesophageal reflux, 0.5% nonalcoholic fatty liver disease, 0.4% Blount disease, and 0.4% type 2 diabetes. Although it is acknowledged that direct comparison of the reported disease prevalence with prospective interventional studies related to adolescent MBS is difficult, these low percentages differ from comorbid illnesses observed among the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABORATORIES) study cohort, the largest prospective observation study of adolescents undergoing MBS. For example, Teen-LABS reported significantly higher rates of obesity-related illnesses, including obstructive sleep apnea (57%), hypertension (45%), nonalcoholic fatty liver disease (37%), type 2 diabetes (14%), and Blount disease (4%), to name a few.14Reading between the lines, the current report not only shows the underuse of MBS to treat severe childhood obesity but serves to highlight the potential lack of evaluation for underlying comorbidities within the affected pediatric population. Furthermore, the highly heterogeneous composition of the study cohort (ie, >65% ethnic minorities) serves to support recent data demonstrating disparities in care related to race, ethnicity, and socioeconomic status of youth undergoing MBS.15,16Although the root causes responsible for a failure to recognize and treat severe obesity are multifactorial, including systemic biases pertaining to the nature and treatment of obesity as a disease and the inadequate access to pediatric obesity–directed multidisciplinary care; the outcome is leaving the current generation of children extremely vulnerable to the cumulative impact of untreated disease. As clearly demonstrated in recent large longitudinal studies, untreated childhood obesity will undoubtedly lead to higher rates of cardiometabolic disease risk and related rates of early mortality.17,18In addition to continued efforts to expand our overarching knowledge related to health outcomes after MBS in the pediatric population, robust efforts must be undertaken to address the systemic shortcomings resulting in significant disparities of care on an individual, organizational, and governmental level as outlined by the AAP. Pediatricians need to heed the AAP recommendations for screening and treatment of comorbidities and obesity simultaneously. Open discussion of MBS and its benefits should start at the primary care level. More centers using advanced therapies for pediatric obesity must be funded by insurance and Centers for Medicare & Medicaid Services. Systemic bias with regard to pediatric obesity and its treatment must be counteracted with better education about the genetic nature, the aggressive progression, and the effective treatments for pediatric obesity. In most pediatric patients meeting BMI eligibility criteria for MBS, surgery will be delayed by limited access to MBS programs, insurance denials, or simply never being referred. The opportunity for a health system like that studied here is immense: as an integrated care system, the institution of standard screening for comorbidities based on BMI and standard referrals to advanced therapies such as MBS could become a reality.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
田様应助dddddddio采纳,获得10
刚刚
丘比特应助精致采纳,获得10
1秒前
Niniiii应助喵星人采纳,获得10
1秒前
lulull完成签到,获得积分10
1秒前
yihuifa完成签到 ,获得积分10
1秒前
爱学习的悦悦子完成签到 ,获得积分10
2秒前
11111完成签到 ,获得积分10
2秒前
昨夜书完成签到,获得积分10
2秒前
_hhhjhhh完成签到,获得积分10
2秒前
友好盼波完成签到,获得积分10
2秒前
Angel完成签到 ,获得积分10
2秒前
趴趴熊完成签到,获得积分10
2秒前
drs完成签到,获得积分10
3秒前
初a完成签到,获得积分10
3秒前
Lensin完成签到 ,获得积分10
4秒前
打打应助why采纳,获得10
4秒前
空白完成签到,获得积分10
4秒前
细心故事完成签到,获得积分10
4秒前
bbanshan完成签到,获得积分10
5秒前
wen完成签到,获得积分10
5秒前
多多肉完成签到,获得积分10
5秒前
Vera完成签到,获得积分10
5秒前
King_li关注了科研通微信公众号
7秒前
7秒前
极夜完成签到,获得积分10
8秒前
sdnihbhew完成签到,获得积分10
8秒前
背后雨柏完成签到 ,获得积分10
8秒前
8秒前
8秒前
默默无闻完成签到,获得积分10
8秒前
勤恳的幻巧关注了科研通微信公众号
9秒前
wenwenwang完成签到 ,获得积分10
9秒前
yangzhang完成签到,获得积分10
10秒前
Anna完成签到,获得积分10
10秒前
兴奋一斩完成签到,获得积分10
11秒前
lf-leo完成签到,获得积分10
11秒前
科目三应助hs采纳,获得10
11秒前
彭a完成签到,获得积分10
11秒前
Karvs完成签到,获得积分10
11秒前
12秒前
高分求助中
Encyclopedia of Mathematical Physics 2nd edition 888
Technologies supporting mass customization of apparel: A pilot project 600
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 500
Arthur Ewert: A Life for the Comintern 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi // Kurt Werner Radtke 500
Two Years in Peking 1965-1966: Book 1: Living and Teaching in Mao's China // Reginald Hunt 500
材料概论 周达飞 ppt 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3808198
求助须知:如何正确求助?哪些是违规求助? 3352921
关于积分的说明 10361382
捐赠科研通 3068951
什么是DOI,文献DOI怎么找? 1685330
邀请新用户注册赠送积分活动 810433
科研通“疑难数据库(出版商)”最低求助积分说明 766150